Urology Doctors in Matthews, NC Accepting Medicare

5 Urology doctors found. Showing 1 - 5

Samuel Stuart Dupuy Jr., M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 1450 Matthews Township Parkway, Matthews, NC 28105 Phone: 704-846-0809    Fax: 704-283-4705

Dr. Bradley Kent Weisner, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 1450 Matthews Township Pkwy, Suite 350, Matthews, NC 28105 Phone: 704-841-8877    Fax: 704-841-8188

Liliya Petrovna Velet, MD Urology Medicare: Medicare Enrolled Practice Location: 1450 Matthews Township Pkwy Ste 350, Matthews, NC 28105 Phone: 704-841-8877    Fax: 704-841-8188

Dr. Roger Jo-chieh Yau, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 1450 Matthews Township Pkwy Ste 350, Matthews, NC 28105 Phone: 704-841-8877    Fax: 704-841-8188

Dr. Thomas Hogeman Phillips, MD Urology Medicare: Medicare Enrolled Practice Location: 1450 Matthews Township Pkwy, Suite 350, Matthews, NC 28105 Phone: 704-841-8877    Fax: 704-841-8188

News Archive

New study shows only half of locally advanced rectal cancer patients receive standard therapy

While use of the standard therapy leading to the best outcome against locally advanced rectal cancer has increased over the past decade, only half of patients currently receive it, according to a new study. The authors of the study say the underutilization could be explained in part by socioeconomic factors. The study appears early online in the American Cancer Society's peer-review journal Cancer.

Study finds increasing trends in use of CVI treatment procedures in Medicare population

A new study by the Harvey L. Neiman Health Policy Institute found that utilization of procedures to treat chronic venous insufficiency (CVI) in the Medicare population increased markedly from 2005 through 2014.

BioLineRx signs out-licensing agreement with CTTQ to develop, commercialize Hepatitis C drug

BioLineRx, a biopharmaceutical development company, announced today that it has signed an out-licensing agreement with Jiangsu Chia-tai Tianqing Pharmaceutical Co., Ltd., the leading Chinese pharmaceutical company in the liver disease therapeutic area, for the development and commercialization of BL-8030, an orally available treatment for the Hepatitis C virus.

When it comes to inflammation, too much of a good thing can be deadly

In some severely injured patients, this normal healing process can develop into a lethal, whole-body response, including bloodstream infection (sepsis) and multiple organ failure. How and why inflammation turns from healing to harming is still mysterious, so doctors can't accurately predict how each injured patient will fare.

Creekridge Capital, Healthland partner to offer financing solutions for healthcare information system

Creekridge Capital LLC, a nationwide independent healthcare and technology vendor leasing company, has signed an agreement with Healthland, a healthcare information technology (HIT) vendor, to offer creative financing solutions under the private label name, Healthland Financing.

Read more Medical News

› Verified 2 days ago